Reimagining Public Health
From pandemics to health inequities, confronting future crises will look different — and that’s a good thing.
From pandemics to health inequities, confronting future crises will look different — and that’s a good thing.
UC San Diego scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.
In the span of just a few weeks, Don Cleveland, a leading researcher in the study of neurodegenerative diseases like ALS and Alzheimer’s, has received three major awards.
UC San Diego and its collaborating partners have been awarded $10 million from the Howard Hughes Medical Institute to leverage the biomedical promise of viruses known as bacteriophages as new therapeutic agents in the fight against the rising crisis of antibiotic-resistant bacterial infections.
UC San Diego Health’s gastroenterology endoscopy program has been recognized as a leader in quality and safety by the American Society for Gastrointestinal Endoscopy (ASGE), the leading national gastrointestinal endoscopy medical society.
The gut microbiome plays a critical but poorly understood role in how drugs work or don't work in the body. It also presents therapeutic possibilities unto itself.
The Atlantic, May 5
New York Post, May 3
La Jolla Light, May 1
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.